Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001273351-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
55,000
Total Value
$0.00
P&L
+inf% (+$4,339,500.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF ACCOUNTING OFFICER | Stock Option (Right to Buy) | Derivative | Feb 3, 2026 | Grant/Award | 55,000 | $0.00 | $0.00 | 55,000 | Direct | โ | View Details |